News
StockStory.org on MSN3h
Pfizer (PFE) Reports Q1: Everything You Need To Know Ahead Of EarningsGlobal pharmaceutical company Pfizer (NYSE:PFE) will be reporting earnings tomorrow before market hours. Here’s what you need ...
22hon MSN
As April gives way to May, the market braces for a blockbuster week packed with earnings from some of the biggest names ...
Reviewing PFE’s five-year history, the stock has experienced a balanced 50-50 distribution of positive and negative returns ...
3d
24/7 Wall St. on MSNPrediction: 1 Biotech Stock That Could Surpass Pfizer by 2030Pfizer (NYSE:PFE) is a global pharmaceutical giant that has long been a cornerstone of medical innovation and today boasts a ...
Pharmaceutical giant Pfizer (PFE) has been through a rough spot in 2025, joining the rest of the stock market as President Donald Trump’s trade ...
4d
Zacks.com on MSNPfizer (PFE) Stock Sinks As Market Gains: What You Should KnowIn the closing of the recent trading day, Pfizer (PFE) stood at $22.36, denoting a -0.78% change from the preceding trading day.
Senator Ron Wyden (D-Ore.), a senior member of the Senate Finance Committee, accused Pfizer (PFE) of carrying out what he ...
Investors interested in Large Cap Pharmaceuticals stocks are likely familiar with Pfizer (PFE) and Eli Lilly (LLY). But which of these two stocks is more attractive to value investors? We'll need ...
We recently published a list of the 10 Safe Dividend Stocks with Yields Above 5%. In this article, we are going to take a ...
Pfizer’s multi-year lows reflect headwinds, lack of catalysts, and fading appeal to both growth and defensive investors. Read why PFE stock is a hold.
Results that may be inaccessible to you are currently showing.
Hide inaccessible results